{"id":1100,"date":"0202-03-11T18:05:27","date_gmt":"0202-03-11T18:20:11","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=1100"},"modified":"2021-05-05T16:32:52","modified_gmt":"2021-05-05T14:32:52","slug":"1100-2","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/1100-2\/","title":{"rendered":"Seguro de vida y accidentes"},"content":{"rendered":"\n<p class=\"has-text-align-justify\">Todos los empleados de Dose Innova en Espa\u00f1a se benefician de un seguro colectivo desde el momento de su incorporaci\u00f3n. El capital asegurado se establece en funci\u00f3n de tramos salariales que garantizan al asegurado o a sus beneficiarios la cobertura de como m\u00ednimo:<\/p>\n\n\n\n<p class=\"has-text-align-justify\">El importe correspondiente al salario bruto fijo anual, en caso de muerte o de incapacidad profesional total y permanente.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">El importe correspondiente a dos veces el salario bruto fijo anual, en caso de muerte por accidente.<\/p>\n\n\n\n<p>En caso de defunci\u00f3n, excepto designaci\u00f3n expr\u00e9s, los beneficiarios del seguro ser\u00e1n:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Para&nbsp;l@s&nbsp;casad@s: el c\u00f3nyuge y en su defecto los descendentes a partes iguales.<\/li><li>Para&nbsp;l@s&nbsp;solter@s: los descendentes a partes iguales y en su defecto los ascendientes.<\/li><li>En ambos casos, a falta de todos los mencionados, los herederos legales.<\/li><\/ul>\n\n\n\n<p>En caso de querer cambiar los beneficiarios del seguro, es importante comunicarlo a&nbsp;RR.HH.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Todos los empleados de Dose Innova en Espa\u00f1a se benefician de un seguro colectivo desde el momento de su incorporaci\u00f3n. El capital asegurado se establece en funci\u00f3n de tramos salariales &#8230; <a title=\"Seguro de vida y accidentes\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/1100-2\/\" aria-label=\"Leer m\u00e1s sobre Seguro de vida y accidentes\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":335,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-1100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-beneficissocials","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=1100"}],"version-history":[{"count":4,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1100\/revisions"}],"predecessor-version":[{"id":3797,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1100\/revisions\/3797"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/335"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=1100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=1100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=1100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}